← Back to Analyst Consensus 
ADMA Buy
ADMA BIOLOGICS, INC.
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jul 15, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| May 7, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| May 7, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Apr 21, 2026 | Canaccord Genuity | initiate | — → Buy | — | 48% |
| Apr 13, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Mar 26, 2026 | Cantor Fitzgerald | downgrade | Overweight → Neutral | — | 50% |
| May 8, 2025 | Raymond James | maintain | Strong Buy → Strong Buy | $32 | 54% |
| Mar 4, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $25 | 50% |
| Nov 8, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $26 | 44% |
| Nov 8, 2024 | Raymond James | maintain | Strong Buy → Strong Buy | $25 | 54% |
| Oct 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Sep 20, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $20 | 50% |
| Aug 12, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $18 | 44% |
| Aug 9, 2024 | Cantor Fitzgerald | maintain | Overweight → Overweight | $20 | 50% |
| Jul 9, 2024 | Cantor Fitzgerald | maintain | Overweight → Overweight | $15 | 50% |
| Jun 20, 2024 | Mizuho | maintain | Buy → Buy | $14 | 52% |
| May 10, 2024 | Raymond James | maintain | Strong Buy → Strong Buy | $10 | 54% |
| May 10, 2024 | Cantor Fitzgerald | maintain | Overweight → Overweight | $10 | 50% |
| May 10, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $10 | 44% |
| May 10, 2024 | Mizuho | maintain | Buy → Buy | $12 | 52% |
| Mar 26, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7.5 | 44% |
| Mar 1, 2024 | Mizuho | maintain | Buy → Buy | $10 | 52% |
| Feb 29, 2024 | Cantor Fitzgerald | maintain | Overweight → Overweight | $8 | 50% |
| Feb 29, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Jan 22, 2024 | Mizuho | maintain | Buy → Buy | $9 | 52% |
| Jan 9, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $6 | 44% |
| Dec 19, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $6 | 50% |
| Nov 17, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Aug 10, 2023 | Cantor Fitzgerald | maintain | Overweight → Overweight | $6 | 50% |
| Aug 10, 2023 | Raymond James | maintain | Strong Buy → Strong Buy | $6 | 54% |
| Aug 10, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| Mar 27, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $4.5 | 44% |
| Feb 8, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $4.5 | 44% |
| Jan 3, 2023 | HC Wainwright & Co. | maintain | — → Buy | $4.5 | 44% |
| Nov 10, 2022 | Mizuho | maintain | — → Buy | $6 | 52% |
| Oct 13, 2022 | Mizuho | initiate | — → Buy | $5 | 52% |
| Jul 25, 2022 | HC Wainwright & Co. | maintain | — → Buy | $4 | 44% |
| Nov 11, 2021 | Raymond James | upgrade | Outperform → Strong Buy | $5 | 54% |
| Nov 9, 2021 | Cantor Fitzgerald | initiate | — → Overweight | $4.5 | 50% |
| Oct 26, 2021 | Raymond James | maintain | — → Outperform | $5 | 54% |
| Aug 12, 2021 | HC Wainwright & Co. | maintain | — → Buy | $6 | 44% |
| Jul 6, 2021 | HC Wainwright & Co. | maintain | — → Buy | $7 | 44% |
| Mar 26, 2021 | Raymond James | maintain | — → Outperform | $6 | 54% |
| Jan 4, 2021 | HC Wainwright & Co. | maintain | — → Buy | $11 | 44% |
| Oct 1, 2020 | Raymond James | maintain | — → Outperform | $7 | 54% |
| May 7, 2020 | Oppenheimer | maintain | — → Outperform | $7 | 52% |
| Mar 16, 2020 | HC Wainwright & Co. | maintain | — → Buy | $12 | 44% |
| Jun 4, 2019 | Jefferies | initiate | — → Buy | $8 | 52% |
| Apr 2, 2019 | Oppenheimer | maintain | Outperform → Outperform | $16 | 52% |
| Oct 30, 2018 | HC Wainwright & Co. | initiate | — → Buy | $17 | 44% |
Price Target Trend
Jun 15, 2026 Oct 26, 2026
EPS Estimates
+1y —
0y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days